Failed Drugs, Loss of Patent: Japanese drugmaker Takeda slashes full-year profit forecast by 36 percent Ruchika Sharma26 Oct 2023 3:21 PM ISTTokyo: Japan's biggest drugmaker Takeda Pharmaceutical has slashed its full-year profit forecast by 36% as it contends with disappointments in...
Takeda to voluntary withdraw lung cancer therapy Exkivity Ruchika Sharma4 Oct 2023 4:30 PM ISTOsaka: Takeda has announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA...
Takeda Pharma gets USFDA nod for cancer treatment EXKIVITY Ruchika Sharma18 Sept 2021 10:00 AM ISTOsaka: Drugmaker, Takeda Pharmaceutical Company Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has...
FDA approves first targeted oral therapy for very rare lung cancer Dr Kartikeya Kohli17 Sept 2021 9:39 AM ISTCAMBRIDGE, Mass - The U.S. Food and Drug Administration (FDA) has approved EXKIVITY (mobocertinib) for the treatment of adult patients with...
